Avidity Biosciences
RNAM
#1786
Rank
โ‚น1.042 T
Marketcap
โ‚น6,748
Share price
0.00%
Change (1 day)
51.08%
Change (1 year)

Earnings for Avidity Biosciences (RNAM)

Earnings in 2025 (TTM): -โ‚น60.17 Billion

According to Avidity Biosciences's latest financial reports the company's current earnings are โ‚น18.75 Million. a decrease over its 2024 earnings that were of -โ‚น29.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avidity Biosciences from 2019 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น63.45 Billion112.42%
2024 -โ‚น29.87 Billion51.87%
2023 -โ‚น19.67 Billion21.97%
2022 -โ‚น16.13 Billion47.44%
2021 -โ‚น10.94 Billion166.06%
2020 -โ‚น4.12 Billion79.33%
2019 -โ‚น2.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น645.72 B-1,117.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น663.00 B-1,145.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น12.14 Billion-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚น7.89 Billion-87.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-โ‚น12.38 Billion-80.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น25.19 Billion-60.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-โ‚น23.68 Billion-62.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น27.47 B-143.30%๐Ÿ‡บ๐Ÿ‡ธ USA